Rabies viral mechanisms to escape the IFN system: The viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies

Journal of Interferon and Cytokine Research

Volumn 26, Issue 5, 2006, Pages 271-280

  Chelbi Alix, Mounira K ^a   Vidy, Aurore ^b   Bougrini, Jamila El ^a   Blondel, Danielle ^b  

^a INSTITUT ANDRÉ LWOFF   (France)

^b INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 3; JANUS KINASE; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN P;

ANTIVIRAL ACTIVITY; CELL NUCLEUS INCLUSION BODY; CYTOKINE PRODUCTION; CYTOPLASM; GENE; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INTERFERON STIMULATED GENE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RABIES VIRUS; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

RNA VIRUSES;

EID: 33744456994     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.271     Document Type: Review

References (76)

1. Isaacs A, Lindenmann J. Virus interference. I. The Interferon. Proc. R. Soc. Lond. B. Biol Sci. 1957;147:258-267.
2. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005;23:307-336.
3. Regad, T, Chelbi-Alix MK. Role and fate of PML nuclear bodies in response to Interferon and viral infections. Oncogene 2001;20: 7274-7286.
4. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu. Rev. Biochem. 1998;67: 227-264.
5. Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 2000;81:2341-2364.
6. Chenik M, Chebli K, Gaudin Y, Blondel D. In vivo interaction of rabies virus phosphoprotein (P) and nucleoprotein (N), existence of two N binding sites on P protein. J. Gen. Virol. 1994;79: 2889-2896.
7. Fu ZF, Zheng Y, Wunner WH, Koprowski H, Dietzschold B. Both the N- and the C-terminal domains of the nominal phosphoprotein of rabies virus are involved in binding to the nucleoprotein. Virology 1994;200:590-597.
8. Schoehn G, Iseni F, Mavrakis M, Blondel D, Ruigrok RW. Structure of recombinant rabies virus nucleoprotein-RNA complex and identification of the phosphoprotein binding site. J. Virol. 2001;75:490-498.
9. Mavrakis M, McCarthy AA, Roche S, Blondel D, Ruigrok RW. Structure and function of the C-terminal domain of the polymerase cofactor of rabies virus. J. Mol. Biol. 2004;343:819-831.
10. Chenik M, Schnell M, Conzelmann KK, Blondel D. Mapping the interacting domains between the rabies virus polymerase and phosphoprotein. J. Virol. 1998;72:1925-1930.
11. Shoji Y, Inoue S, Nakamichi K, Kurane I, Sakai T, Morimoto K. Generation and characterization of P gene-deficient rabies virus. Virology 2004;318:295-305.
12. Blondel D, Regad T, Poisson N, Pavie B, Harper F, Pandolfi PP, De The H, Chelbi-Alix MK. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 2002;21:7957-7970.
13. Jacob Y, Badrane H, Ceccaldi PE, Tordo N. Cytoplasmic dynein Lc8 interacts with the LC8 dynein light chain. J. Virol. 2000;74: 10217-10222.
14. Raux H, Flamand A, Blondel D. Interaction of the rabies virus P protein with the LC8 dynein light chain. J. Virol. 2000;74: 10212-10216.
15. Vidy A, Chelbi-Alix MK, Blondel D. Rabies virus P protein interacts with Stat1 and inhibits interferon signal transduction pathways. J. Virol. 2005;79:14411-14420.
16. Brzozka K, Finke S, Conzelmann KK. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 2005;79:7673-7681.
17. Gupta A, Blondel D, Choudhary S, Banerjee A. Phosphoprotein (P) of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C. J. Virol. 2000;74:91-98.
18. Chenik M, Chebli K, Blondel D. Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism. J. Virol. 1995;69:707-712.
19. Pasdeloup D, Poisson N, Raux H, Gaudin Y, Ruigrok RW, Blondel D. Nucleocytoplasmic shuttling of the rabies virus P protein requires a nuclear localization signal and a CRM1-dependent nuclear export signal. Virology. 2005;334:284-293.
20. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. Ikkepsilon and Tbk1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003;4:491-496.
21. Sharma S, TenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003;300:1148-1151.
22. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. The RNA helicase RIG-1 has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004;5:730-737.
23. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-1. J. Virol. 2005;79:2689-2699.
24. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. IPS-1, an adaptor triggering RIG-1- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005;10:981-988.
25. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of Mavs, a mitochondrial antiviral signaling protein that activates NF-κb and IRF3. Cell 2005;122:669-682.
26. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005;437:1167-1172.
27. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 2005;19:727-740.
28. Malmgaard L. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 2004;24:439-454.
29. Barnes B, Lubyova B, Pitha PM. On the role of IRF in host defense. J. Interferon Cytokine Res. 2002;22:59-71.
30. Finke S, Brzozka K, Conzelmann KK. Tracking fluorescence-labeled rabies virus: enhanced green fluorescent protein-tagged phosphoprotein P supports virus gene expression and formation of infectious particles. J. Virol. 2004;78:12333-12343.
31. Komatsu T, Takeuchi K, Yokoo J, Gotoh B. C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 2004;325:137-148.
32. Donelan NR, Dauber B, Wang X, Basler CF, Wolff T, Garcia-Sastre A. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J. Virol. 2004;78:11574-11582.
33. Talon J, Horvath CM, Policy R, Basler CF, Muster T, Palese P, Garcia-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 2000; 74:7989-7996.
34. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, Bray M, Klenk HD, Palese P, Garcia-Sastre A. The Ebola virus Vp35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 2003;77:7945-7956.
35. Foy E, Li K, Wang C, Sumpter R Jr, Ikeda M, Lemon SM, Gale M Jr. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003;300:1145-1148.
36. He B, Paterson RG, Stock N, Durbin JE, Durbin RK, Goodbourn S, Randall RE, Lamb RA. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: The multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 2002;303:15-32.
37. Delhaye S, Van Pesch V, Michiels T. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 2004;78:4357-4362.
38. Jennings S, Martinez-Sobrido L, Garcia-Sastre A, Weber F, Kochs G. Thogoto virus M1 protein suppresses IRF3 function. Virology 2005;331:63-72.
39. Graff JW, Mitzel DN, Weisend CM, Flenniken ML, Hardy ME. Interferon regulatory factor 3 is a cellular partner of rotavirus Nsp1. J. Virol. 2002;76:9545-9550.
40. Barro M, Patton JT. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. USA 2002;102:4114-4119.
41. La Rocca SA, Herbert RJ, Crooke H, Drew TW, Wileman TE, Powell PP. Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro. J. Virol. 2005;79:7239-7247.
42. Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 2000;81:2341-2364.
43. Horvath CM. Weapons of Stat destruction. Interferon evasion by paramyxovirus V protein. Eur. J. Biochem. 2004;271:4621-4628.
44. Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM, Horvath CM. Stat protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 2003;77: 7635-7644.
45. Yokota S, Saito H, Kubota T, Yokosawa N, Amano K, Fujii N. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex. Virology 2003;306:135-146.
46. Yokosawa N, Yokota S, Kubota T, Fujii N. C-terminal region of Stat-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J. Virol. 2002;76:12683-12690.
47. Young DF, Andrejeva L, Livingstone A, Goodbourn S, Lamb RA, Collins PL, Elliott RM, Randall RE. Virus replication in engineered human cells that do not respond to interferons. J. Virol. 2003;77: 2174-2181.
48. Kubota T, Yokosawa N, Yokota S, Fujii N, Tashiro M, Kato A. Mumps virus V protein antagonizes interferon without the complete degradation of Stat1. J. Virol. 2005;79:4451-4459.
49. Kato A, Cortese-Grogan C, Moyer SA, Sugahara F, Sakaguchi T, Kubota T, Otsuki N, Kohase M, Tashiro M, Nagai Y. Characterization of the amino acid residues of Sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation. J. Virol. 2004;78:7443-7454.
50. Nishio M, Tsurudome M, Ito M, Garcin D, Kolakofsky D, Ito Y. Identification of paramyxovirus V protein residues essential for Stat protein degradation and promotion of virus replication. J. Virol. 2005;79:8591-8601.
51. Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 2001; 283:230-239.
52. Shaw M, Garcia-Sastre A, Palese P, Basler CF. Nipah virus V and W proteins have a common Stat1-binding domain yet inhibit Stat1 activation from the cytoplasmic and nuclear compartments, respectively. J. Virol. 2004;78:5633-5641.
53. Rodriguez JJ, Cruz CD, Horvath CM. Identification of the nuclear export signal and Stat-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J. Virol. 2004;78:5358-5367.
54. Lo MS, Brazas RM, Holtzman MJ. Respiratory syncytial virus non-structural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 2005;79:9315-9319.
55. Ramaswamy M, Shi L, Varga SM, Bank S, Behlke MA, Look DC. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006;344:328-339.
56. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 2003;100:14333-14338.
57. Guo JT, Hayashi J, Seeger C. West Nile virus inhibits the signal transduction pathway of alpha interferon. J. Virol. 2005;79: 1343-1350.
58. Liu WJ, Wang XJ, Mokhonov VV, Shi PY, Randall R, Khromykh AA. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of Stat1 and Stat2 activation by nonstructural proteins. J. Virol. 2005;79: 1934-1942.
59. Lin W, Choe WH, Hiasa Y, Kamegaya Y, Blackard JT, Schmidt EV, Chung RT. Hepatitis C virus expression suppresses interferon signaling by degrading Stat1. Gastroenterology 2005;128:1034-1041.
60. Melen K, Fagerlund R, Nyqvist M, Keskinen P, Julkunen I. Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of Stats. J. Med. Virol. 2004;73:536-547.
61. Jensen K, Shiels C, Freemont PS. PML protein isoforms and the RBCC/TRIM motif. Oncogene 2001;20:7223-7233.
62. Chelbi-Alix MK, Pelicano L, Quignon F, Koken MH, Venlurini L, Stadler M, Pavlovic J, Degos L, de The H. Induction of the PML protein by interferons in normal and APL cells. Leukemia 1995;9:2027-2033.
63. Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saib A, Quignon F, Pelicano L, Guillemin MC, Schindler C, de The H. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 1995;11:2565-2573.
64. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, KamitanI T, Yeh ET, Strauss JF, Maul GG. PML is critical for ND10 formation and recruits the PML-interacting protein DAXX to this nuclear structure when modified by Sumo-1. J. Cell. Biol. 1999;147:221-234.
65. Muller S, Dejean A. Viral immediate-early proteins abrogate the modification by Sumo-1 of Pml and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 1999;73:5137-5143.
66. Bernardi, R, Pandolfi PP. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene. 2003;22: 9048-9057.
67. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, De The H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 1998;72:1043-1051.
68. Dellaire G, Bazett-Jones DP. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 2004;26: 963-977.
69. Regad T, Saib A, Lallemand-Breitenbach V, Pandolfi PP, De The H, Chelbi-Alix MK. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J. 2001;20:3495-3505.
70. Salomoni P, Pandolfi PP. The role of PML in tumor suppression. Cell 2002;108:165-170.
71. Chelbi-Alix MK, De The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 1999;18:935-941.
72. Everett RD. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 2001;20:7266-7273.
73. Bonilla WV, Pinschewer DD, Klenerman P, Rousson V, GaboI M, Pandolfi PP, Zinkernagel RM, Salvato MS, Hengartner H. Effects of promyelocytic leukemia protein on virus-host balance. J. Virol. 2002;76:3810-3818.
74. Campbell Dwyer EJ, Lai H, MacDonald RC, Salvato MS, Borden KL. The lymphocytic choriomeningitis virus ring protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a ring-dependent manner. J. Virol. 2000;74:3293-3300.
75. Borden KL, Campbell Dwyer EJ, Salvato MS. An arenavirus ring (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 1998;72:758-766.
76. Djavani M, Rodas J, Lukashevich LS, Horejsh D, Pandolfi PP, Borden KL, Salvato MS. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J. Virol. 2001;75:6204-6208.